For the fourth year in a row, the Medicines Patent Pool (MPP) has been recognized as a High Performer in the 2025 Global Health 50/50 Report: Holding the Line. At a time when commitments to gender equality are slipping across the global health sector, MPP is strengthening ours. Our continued strong performance reflects our unwavering commitment to fairness, equity and inclusion — principles rooted in the realities of the communities we serve.

Click here to access the full report

 

 

 

 

 

 

 

 

 

 

 

In 2024, MPP adopted a new Menstrual and Menopause Policy, offering flexible work arrangements, awareness-raising, and training to better support women’s health needs. We are pleased to see this initiative featured in the report, recognising it as an important step forward for equity in the workplace.

This policy is part of MPP’s broader approach to ensure our staff feel supported and empowered to thrive at all stages of their professional and personal lives.

“This recognition proves that policies grounded in lived realities can be powerful levers for change. At MPP, we are proud of our progress — but we know there is more to do. We remain determined to push further for equity, inclusion and fairness, in our workplace and in the communities we serve.” Charles Gore, Executive Director, MPP

Looking ahead

Being recognised as a High Performer is not the finish line. MPP will continue to strengthen workplace equity and inclusion policies, monitor progress through data and transparency, champion diversity in leadership and governance and ensure our values are reflected in how we serve people worldwide.

Explore the report

Read the 2025 Global Health 50/50 Report: Holding the Line

Download MPP’s full report